Episode 119: Phase 2 HOPE clinical trial results
This EANcast episode features Dr. Theodoros Mavridis interviewing Professor Messoud Ashina on cutting-edge migraine research. Professor Ashina delves into the PACAP pathway's significance and explores promising therapeutic strategies, including PAC antagonism. The discussion highlights recent clinical trials, such as the HOPE trial, investigating novel monoclonal antibodies for migraine treatment and prevention.Topics in this course:
